Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma - Related Studies

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

This study has been completed.

Study NCT00003937. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer-Related Problem/Condition
		Sarcoma

2	Additional conditions recognized in this trial
		Osteosarcoma

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Bone Tissue
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Connective Tissue

4	Interventions listed in this trial
		cisplatin
		dexrazoxane hydrochloride
		doxorubicin hydrochloride
		etoposide
		ifosfamide
		methotrexate
		conventional surgery

5	Additional drug interventions recognized in this trial
		Doxorubicin
		Razoxane

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Cardiovascular Agents
		Chelating Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Children's Oncology Group
		National Cancer Institute (NCI)